Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sterling-Winthrop Animal Health was the veterinary and livestock division of Sterling Drug, a major American pharmaceutical company. The division specialized in the development and commercialization of vaccines, parasiticides, and anti-infectives for both companion animals and livestock. Historically significant for its broad portfolio of veterinary medicines, the business was a key player in the global animal health market during the mid-20th century. In 1994, following the acquisition of Sterling-Winthrop by Sanofi and the subsequent divestiture of various units, the animal health business was integrated into Sanofi's animal health operations, which later merged with Merck's AgVet to form Merial.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sterling Foster Animal Health.